Calian Group Ltd.
CLNFF
$27.77
-$0.385-1.37%
| Weiss Ratings | CLNFF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | C | |||
| Rating Factors | CLNFF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Good | |||
| Growth Index | Weak | |||
| Efficiency Index | Good | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | CLNFF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.31 | |||
| Price History | CLNFF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 1.78% | |||
| 30-Day Total Return | -22.33% | |||
| 60-Day Total Return | -18.17% | |||
| 90-Day Total Return | -20.49% | |||
| Year to Date Total Return | -16.70% | |||
| 1-Year Total Return | -37.07% | |||
| 2-Year Total Return | -34.47% | |||
| 3-Year Total Return | -39.82% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -32.37% | |||
| 52-Week Low % Change | 1.78% | |||
| Price | CLNFF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $41.06 | |||
| 52-Week Low Price | $27.28 | |||
| 52-Week Low Price (Date) | Mar 04, 2025 | |||
| 52-Week High Price (Date) | Jun 28, 2024 | |||
| Valuation | CLNFF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 330.53M | |||
| Enterprise Value | 399.84M | |||
| Price/Earnings (TTM) | 97.83 | |||
| Earnings Per Share (TTM) | 0.28 | |||
| Earnings Per Share Growth | -77.10% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.60 | |||
| Price/Book (Q) | 1.44 | |||
| Enterprise Value/Revenue (TTM) | 0.72 | |||
| Price | $27.77 | |||
| Enterprise Value/EBITDA (TTM) | 7.14 | |||
| Enterprise Value/EBIT | 14.01 | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | CLNFF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 11.92M | |||
| Dividend Yield | 2.88% | |||
| Div. Per Share (Most Recent) | $0.19 | |||
| Dividend Per Share (TTM) | $0.80 | |||
| Payout Ratio (TTM) | 278.99% | |||
| Dividend Per Share (Most Recent) | $0.19 | |||
| Company Info | CLNFF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 613 599 8600 | |||
| Address | 770 Palladium Drive Ottawa, ON K2V 1C8 | |||
| Website | www.calian.com | |||
| Country | Canada | |||
| Year Founded | 1982 | |||
| Profitability | CLNFF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 5.12% | |||
| Profit Margin | 0.63% | |||
| Management Effectiveness | CLNFF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 3.39% | |||
| Return on Equity | 1.47% | |||
| Income Statement | CLNFF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 549.50M | |||
| Total Revenue (TTM) | 549.50M | |||
| Revenue Per Share | $46.11 | |||
| Gross Profit (TTM) | 186.01M | |||
| EBITDA (TTM) | 55.27M | |||
| EBIT (TTM) | 28.15M | |||
| Net Income (TTM) | 3.49M | |||
| Net Income Avl. to Common (TTM) | 3.49M | |||
| Total Revenue Growth (Q YOY) | 0.37% | |||
| Earnings Growth (Q YOY) | -117.17% | |||
| EPS Diluted (TTM) | 0.28 | |||
| EPS Diluted Growth (Q YOY) | -117.51% | |||
| Balance Sheet | CLNFF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 42.42M | |||
| Cash Per Share (Q) | $3.56 | |||
| Total Current Assets (Q) | 202.99M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 226.32M | |||
| Current Ratio (Q) | 1.445 | |||
| Book Value Per Share (Q) | $19.24 | |||
| Total Assets (Q) | 505.04M | |||
| Total Current Liabilities (Q) | 140.46M | |||
| Total Debt (Q) | 111.71M | |||
| Total Liabilities (Q) | 278.72M | |||
| Total Common Equity (Q) | 226.32M | |||
| Cash Flow | CLNFF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -45.38M | |||
| Cash from Financing (TTM) | -2.91M | |||
| Net Change in Cash (TTM) | 6.20M | |||
| Levered Free Cash Flow (TTM) | 54.44M | |||
| Cash from Operations (TTM) | 54.49M | |||
